Waiting for thyroid biopsy results is stressful, and the report itself can be hard to interpret because it uses a numbered classification rather than plain language. This guide translates each possible result into what it actually means for you and what typically happens next.
Your Report Will Name a Category
Thyroid biopsy results are reported using the Bethesda System, which sorts findings into six categories numbered I through VI. Your report may state the number, the descriptive term, or both. The category determines the estimated likelihood of cancer and the recommended next step.
What Each Result Means
Category I — Non-Diagnostic (5–10% malignancy risk)
What it means: The sample did not contain enough usable cells to make a determination. This is a problem with the sample, not a finding about the nodule.
Why it happens: Most often with cystic nodules, where the needle draws mostly fluid, or when blood obscures the slide.
What happens next: A repeat biopsy after 6 to 12 weeks, often with a cytotechnologist checking adequacy on the spot.
Category II — Benign (0–3% malignancy risk)
What it means: The cells are normal. This is the most common result by a wide margin, seen in roughly 60 to 70 percent of thyroid biopsies.
Common underlying diagnoses: Benign follicular nodule, Hashimoto thyroiditis, colloid nodule.
What happens next: Routine ultrasound follow-up, typically at 12 to 24 months. No surgery or treatment is needed for the nodule itself.
Category III — Atypia of Undetermined Significance (6–18%)
What it means: Some cells looked slightly unusual, but not clearly abnormal enough to classify further. This is an uncertain result by design, not a sign that something was missed.
What happens next: Repeat FNA, molecular testing on the existing sample, or continued surveillance depending on the ultrasound appearance and your clinical picture.
Category IV — Follicular Neoplasm (10–40%)
What it means: The cells form a follicular pattern that could represent either a benign adenoma or a follicular carcinoma. Cytology fundamentally cannot separate the two, because that distinction requires examining whether the tumor has invaded its own capsule, which needs intact tissue.
What happens next: Molecular testing may clarify the risk. Otherwise, diagnostic surgery to remove the lobe allows definitive examination.
Category V — Suspicious for Malignancy (45–60%)
What it means: The cells show features strongly suggesting cancer, most often papillary thyroid carcinoma, but not quite enough for a definitive diagnosis.
What happens next: Surgery is generally recommended, either lobectomy or total thyroidectomy depending on the nodule and your circumstances.
Category VI — Malignant (94–99%)
What it means: The cells are diagnostic of cancer. Papillary thyroid carcinoma is by far the most common type identified.
What happens next: Surgical planning and staging. It is worth knowing that papillary thyroid carcinoma has an excellent prognosis, with 5-year survival exceeding 98 percent in most series.
If your result is Category I or III, that is not bad news. Both frequently lead to a repeat test rather than anything more serious, and Category I says nothing at all about whether the nodule is benign or malignant.
When counseling on indeterminate results, present the malignancy risk as a range and note that institutional rates vary from the published figures. NIFTP reclassification lowered effective malignancy rates in Categories III through V relative to the original Bethesda estimates.
Questions Worth Asking
- Which Bethesda category did my biopsy return?
- Is molecular testing available and would it change the plan?
- If surveillance is recommended, when is the next ultrasound and what change would prompt action?
- If surgery is recommended, is lobectomy an option rather than total thyroidectomy?
Related Reading
For the complete category framework, see the Bethesda system guide. To understand the imaging that led to the biopsy, use the TI-RADS calculator and read what your TI-RADS score means.
Frequently Asked Questions
What does a benign thyroid biopsy result mean?
A benign result is Bethesda Category II, the most common outcome, occurring in roughly 60 to 70 percent of thyroid biopsies. The malignancy risk after a benign FNA is only 0 to 3 percent. Management is usually periodic ultrasound follow-up rather than any intervention.
What does indeterminate mean on a thyroid biopsy?
Indeterminate refers to Bethesda Categories III and IV, where the cells show some abnormal features but not enough to call the nodule clearly benign or malignant. Malignancy risk ranges from about 6 to 40 percent depending on the exact category. Options include repeat biopsy, molecular testing, or diagnostic surgery.
How long does it take to get thyroid biopsy results?
Most laboratories return thyroid cytology results within 3 to 10 business days. Molecular testing, if ordered on an indeterminate sample, typically adds another one to two weeks.
Can a thyroid biopsy be wrong?
No test is perfect, but thyroid FNA is highly reliable at its extremes. A benign result carries a false negative rate of roughly 0 to 3 percent, and a malignant result is correct in 94 to 99 percent of cases. The indeterminate categories are uncertain by design rather than by error.